Original Research Articles
Download PDF (8.65 MB)
Journal of Structural Heart Disease, May 2015, Volume 1, Issue 1:20-32
DOI: 10.12945/j.jshd.2015.00009-14
Balloon Aortic Valvuloplasty: Patient Selection and Technical Considerations
Ted Feldman, MD, FESC, FACC, MSCAI, Mohammad Sarraf, MD, Wes Pedersen, MD, FACC, FSCAI
Evanston Hospital, NorthShore University Health System, Evanston, Illinois
Abstract
BAV has had resurgence in association with the dissem- ination of TAVR. The lack of clear mortality benefit from BAV does not translate to lack of efficacy as a palliative therapy. BAV remains a useful bridge to surgical AVR or TAVR, and for symptom relief in patients who are not candidates for either AVR approach. It is also useful as a diagnostic test for patients with low gradient-low out- put AS, and for those with mixed pulmonary and aortic valvular disease. BAV is used commonly for TAVR pre dilatation, and this is sometimes helpful for annulus size assessment. Careful attention to balloon diameter selection and the details of technique are important for optimizing outcomes.
Cite this article as: Feldman T, Sarraf M, Pedersen W. Balloon Aortic Valvuloplasty: Patient Selection and Technical Considerations. Structural Heart Disease 2015;1(1):20-32. DOI: 10.12945/j.jshd.2015.00009-14
All comments will be screened and reviewed before posting. Statements, opinions, and results of studies published in Journal of Structural Heart Disease are those of the authors and do not reflect the policy or position of The Journal and Science International and the Editorial Board and provides no warranty as to their accuracy or reliability. Material is copyrighted and owned by Science International and cannot be used without expressed permission.
Original Research Articles
Journal of Structural Heart Disease, May 2015, Volume 1, Issue 1:20-32
DOI: 10.12945/j.jshd.2015.00009-14
Balloon Aortic Valvuloplasty: Patient Selection and Technical Considerations
Ted Feldman, MD, FESC, FACC, MSCAI, Mohammad Sarraf, MD, Wes Pedersen, MD, FACC, FSCAI
Evanston Hospital, NorthShore University Health System, Evanston, Illinois
Abstract
BAV has had resurgence in association with the dissem- ination of TAVR. The lack of clear mortality benefit from BAV does not translate to lack of efficacy as a palliative therapy. BAV remains a useful bridge to surgical AVR or TAVR, and for symptom relief in patients who are not candidates for either AVR approach. It is also useful as a diagnostic test for patients with low gradient-low out- put AS, and for those with mixed pulmonary and aortic valvular disease. BAV is used commonly for TAVR pre dilatation, and this is sometimes helpful for annulus size assessment. Careful attention to balloon diameter selection and the details of technique are important for optimizing outcomes.
PDF
Mobile-ready Flipbook
Cite this article as: Feldman T, Sarraf M, Pedersen W. Balloon Aortic Valvuloplasty: Patient Selection and Technical Considerations. Structural Heart Disease 2015;1(1):20-32. DOI: 10.12945/j.jshd.2015.00009-14
You must be registered and logged in to leave comments.
There have been no comments posted yet
Ask a question (publicly)
Board